olmesartan has been researched along with Sensitivity and Specificity in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukami, T; Hosomi, H; Iwamura, A; Nakajima, M; Yokoi, T | 1 |
Hu, P; Jiang, J; Qi, W; Zhao, Q | 1 |
Imai, K; Tsunoda, M; Yamagishi, M; Yanagisawa, T | 1 |
Kato, M; Mizuno, M; Sada, T; Terashima, H; Tsuchida, H; Yasumo, H | 1 |
Patil, KR; Rane, VP; Sangshetti, JN; Shinde, DB; Yeole, RD | 1 |
Dong, YF; Kataoka, K; Kim-Mitsuyama, S; Lai, ZF; Matsuba, S; Ogawa, H; Tanaka, T; Tokutomi, Y; Yamamoto, E; Yamashita, T | 1 |
Hu, P; Jiang, J; Li, L; Li, X; Liu, D; Matsushima, N | 1 |
7 other study(ies) available for olmesartan and Sensitivity and Specificity
Article | Year |
---|---|
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay.
Topics: Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Benzbromarone; Biotransformation; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Diclofenac; HEK293 Cells; Hep G2 Cells; Hepatocytes; Humans; Losartan; NF-E2-Related Factor 2; Semicarbazides; Sensitivity and Specificity; Time Factors; Uricosuric Agents | 2011 |
Simultaneous determination of olmesartan and amlodipine in human plasma and urine by ultra performance liquid chromatography tandem mass spectrometry.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Humans; Imidazoles; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tetrazoles | 2013 |
Study of the acute cardiovascular effects of several antihypertensive agents with the measurement of plasma catecholamines in mice.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Captopril; Catecholamines; Chromatography, High Pressure Liquid; Heart Rate; Imidazoles; Luminescence; Male; Mice; Mice, Inbred C57BL; Nicardipine; Nitroprusside; Oxalates; Reproducibility of Results; Sensitivity and Specificity; Tetrazoles; Time Factors | 2009 |
A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzamides; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Dioxoles; Disease Models, Animal; Fibrosis; Genes, Reporter; Hydroxyproline; Imidazoles; Kidney; Luciferases; Male; Protein Serine-Threonine Kinases; Rats; Rats, Transgenic; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Sensitivity and Specificity; Tetrazoles; Ureteral Obstruction | 2010 |
Stability indicating LC method for the simultaneous determination of amlodipine and olmesartan in dosage form.
Topics: Acetonitriles; Amlodipine; Chemistry, Pharmaceutical; Chromatography, Liquid; Drug Stability; Hydrolysis; Imidazoles; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tetrazoles | 2010 |
Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
Topics: Animals; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Pravastatin; Rats; Rats, Inbred Dahl; Reference Values; Risk Factors; Sensitivity and Specificity; Sodium Chloride, Dietary; Tetrazoles; Vascular Diseases | 2007 |
Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.
Topics: Angiotensin II Type 1 Receptor Blockers; Chromatography, High Pressure Liquid; Female; Humans; Imidazoles; Male; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tetrazoles | 2007 |